Stockscreener 앱 받기
10.16
0.00%
0.000100
시간 외 거래:
10.16
-0.000100
-0.00%
전일 마감가:
$10.16
열려 있는:
$10
하루 거래량:
2,027
Relative Volume:
0.01
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.20%
1개월 성능:
+0.32%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.00
$10.16
1주일 범위
$10.00
$10.16
52주 변동 폭
$10.00
$10.82
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
954-870-3104
주소
2 PELICAN DR., FORT LAUDERDALE
DMAAU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.16 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.63 | 1.80B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.20 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.67 | 460.58M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.27 | 455.13M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.09 | 450.63M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp 주식(DMAAU)의 최신 뉴스
Pfizer Inc. - Britannica
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica
Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette
'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo
Drugs Made In America Acquisition Corp. (DMAA) reports earnings - qz.com
Bright Green Unveils Massive $2B Cannabis Strategy with Zero Shareholder Dilution - StockTitan
Bright Green Corporation Announces the next steps for the completion of its restructuring plan - The Manila Times
DRUGS MADE IN AMERICA ACQUISITION CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
India-based Syngene acquires its first US biologics site - Manufacturing Dive
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger - Reuters
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Q1 Earnings Estimate for WSP Global Issued By Raymond James - Defense World
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
adidas AG (OTCMKTS:ADDYY) Sees Large Growth in Short Interest - Defense World
ACS, Actividades de Construcción y Servicios, S.A. (OTCMKTS:ACSAY) Short Interest Up 104.9% in February - Defense World
Acorn Energy, Inc. (OTCMKTS:ACFN) Sees Large Increase in Short Interest - Defense World
Smithfield Foods, Inc’s (NASDAQ:SFD) Quiet Period Set To Expire on March 10th - Defense World
Short Interest in ANA Holdings Inc. (OTCMKTS:ALNPY) Decreases By 33.3% - Defense World
Alfa S.A.B. de C.V. (OTCMKTS:ALFFF) Short Interest Up 79.6% in February - Defense World
AIA Group Limited (OTCMKTS:AAGIY) Short Interest Update - Defense World
Aker ASA (OTCMKTS:AKAAF) Short Interest Up 61.0% in February - Defense World
Athena Gold Co. (OTCMKTS:AHNR) Sees Significant Growth in Short Interest - Defense World
Short Interest in Agricultural Bank of China Limited (OTCMKTS:ACGBF) Increases By 74.0% - Defense World
Short Interest in Alaris Equity Partners Income Trust (OTCMKTS:ADLRF) Grows By 137.9% - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Update - Defense World
Financial Comparison: Thomasville Bancshares (OTCMKTS:THVB) & U.S. Bancorp (NYSE:USB) - Defense World
OSI Systems (NASDAQ:OSIS) vs. Applied Optoelectronics (NASDAQ:AAOI) Critical Contrast - Defense World
Endava plc (NYSE:DAVA) Receives $39.10 Consensus Target Price from Brokerages - Defense World
Sanctuary Advisors LLC Has $782,000 Stake in Vornado Realty Trust (NYSE:VNO) - Defense World
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines - Business Wire
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Eli Lilly and Company
A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - CNN
BGXXBright Green Corp Latest Stock News & Market Updates - StockTitan
Drugs Made in America Acquisition Corp. Announces Advisory Team - The Manila Times
CanadaHelps Estimates $266 Million Loss for Charities Due to Canada Post Strike; Urges Canadians to Use Extended Donation Deadline to Give - The Manila Times
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Can This Power Team of Healthcare Veterans Reshape American Drug Manufacturing? - StockTitan
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com
SPAC Alert: Key Trading Change Coming for Drugs Made In America UnitsWhat Investors Should Track - StockTitan
Drugs Made In America Acquisition Corp. Announces Trading Options for Public Offering Units Starting February 25, 2025 - Nasdaq
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com
ForexTV | Small Business Resources - ForexTV.com
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO ... - The Bakersfield Californian
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView
Nortech Systems (NASDAQ:NSYS) Coverage Initiated by Analysts at StockNews.com - Defense World
Drugs Made In America Acquisition Corp (DMAAU) 재무 분석
Drugs Made In America Acquisition Corp (DMAAU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.53%
0.00%
자본화:
|
볼륨(24시간):